STERIS announced a 15% increase in revenue to $1.40 billion for the third quarter of fiscal 2024. As reported diluted earnings per share increased to $1.42, and adjusted earnings per share increased to $2.22. The company updated its fiscal 2024 outlook, expecting revenue to increase by 10-11% and adjusted earnings per diluted share to be in the range of $8.60 to $8.70.
Third quarter revenue increased by 15% as reported, with a 10% increase in constant currency organic revenue.
As reported diluted earnings per share increased to $1.42; adjusted earnings per share increased to $2.22.
The Healthcare segment experienced continued momentum, reflecting solid procedure volume growth in the United States and the easing of supply chain constraints.
Revenue outlook for fiscal 2024 has increased due to outperformance within the Healthcare segment.
For fiscal year 2024, STERIS expects as reported revenue to increase 10-11%, with constant currency organic revenue growth of 7-8%. Adjusted earnings per diluted share are anticipated to be in the range of $8.60 to $8.70.
Visualization of income flow from segment revenue to net income